Simon Phipps

Simon Phipps

Auto-generated profile, based on publicly available information

Simon Phipps

Respiratory Immunology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Clinical & Experimental Allergy
Verified
Journal Article
Open access
PDF file
SHSimon P. Hogan
Simon P. Hogan
HRHelene F. Rosenberg
Helene F. Rosenberg
RMRedwan Moqbel
Redwan Moqbel
SPSimon Phipps
Simon Phipps
PFPaul S. Foster
Paul S. Foster
MRMarc E. Rothenberg
Marc E. Rothenberg
SUMMARY: Eosinophils are pleiotropic multifunctional leukocytes involved in initiation and propagation of diverse inflammatory responses, as well as modulators of innate and adaptive immunity. In this review, the biology of eosinophils is summarized, focusing on transcriptional regulation of eosinophil differentiation, characterization of the growing properties of eosinophil granule proteins, surface proteins and pleiotropic mediators, and molecular mechanisms of eosinophil degranulation. New views on the role of eosinophils in homeostatic function are examined, including developmental biology and innate and adaptive immunity (as well as their interaction with mast cells and T cells) and their proposed role in disease processes including infections, asthma, and gastrointestinal disorders. Finally, strategies for targeted therapeutic intervention in eosinophil‐mediated mucosal diseases are conceptualized.

1 January 2010 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
MHMark R Hutchinson
Mark R Hutchinson
YZYingning Zhang
Yingning Zhang
MSMitesh Shridhar
Mitesh Shridhar
JEJohn H. Evans
John H. Evans
MBMadison M. Buchanan
Madison M. Buchanan
LWLinda R. Watkins
Linda R. Watkins

3 November 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JMJoerg Mattes
Joerg Mattes
ACAdam Collison
Adam Collison
MPMaximilian Plank
Maximilian Plank
SPSimon Phipps
Simon Phipps
PFPaul S. Foster
Paul S. Foster
Allergic asthma is an inflammatory disease of the lung characterized by abnormal T helper-2 (T H 2) lymphocyte responses to inhaled antigens. The molecular mechanisms leading to the generation of T H 2 responses remain unclear, although toll-like receptors (TLRs) present on innate immune cells play a pivotal role in sensing molecular patterns and in programming adaptive T cell responses. Here we show that in vivo activation of TLR4 by house dust mite antigens leads to the induction of allergic disease, a process that is associated with expression of a unique subset of small, noncoding microRNAs. Selective blockade of microRNA (miR)-126 suppressed the asthmatic phenotype, resulting in diminished T H 2 responses, inflammation, airways hyperresponsiveness, eosinophil recruitment, and mucus hypersecretion. miR-126 blockade resulted in augmented expression of POU domain class 2 associating factor 1, which activates the transcription factor PU.1 that alters T H 2 cell function via negative regulation of GATA3 expression. In summary, this study presents a functional connection between miRNA expression and asthma pathogenesis, and our data suggest that targeting miRNA in the airways may lead to anti-inflammatory treatments for allergic asthma.

1 June 2007 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
HRHelene Rosenberg
Helene Rosenberg
SPSimon Phipps
Simon Phipps
PFPaul S. Foster
Paul S. Foster

17 October 2013 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
JSJodie L. Simpson
Jodie L. Simpson
SPSimon Phipps
Simon Phipps
KBKatherine Baines
Katherine Baines
KOKevin M. Oreo
Kevin M. Oreo
LGLakshitha Gunawardhana
Lakshitha Gunawardhana
PGpeter gibson
peter gibson
Asthma is a heterogeneous inflammatory airways disorder where interleukin (IL)-1β is thought to be a key mediator, especially in the neutrophilic subtype of asthma. The generation of active IL-1β requires proteolytic cleavage typically mediated through the formation of a caspase-1-containing inflammasome. This study hypothesised that an IL-1β endotype associated with the nucleotide-binding domain, leucine-rich repeat-containing family protein (NLRP)3/apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC)/caspase-1 inflammasome is characteristic of patients with the neutrophilic subtype of asthma.Participants with asthma (n=85) and healthy controls (n=27) underwent clinical assessment, spirometry and sputum induction. Sputum was processed for differential cell count, gene expression and protein mediators. NLRP3 and caspase-1 expression was also determined by immunocytochemistry. Sputum macrophages were isolated (n=8) and gene expression of NLRP3 and IL-1β determined.There was significantly elevated gene expression of NLRP3, caspase-1, caspase-4, caspase-5 and IL-1β in participants with neutrophilic asthma. Protein levels of IL-1β were significantly higher in those with neutrophilic asthma and correlated with sputum IL-8 levels. Sputum macrophages, as well as sputum neutrophils in neutrophilic asthma, expressed NLRP3 and caspase-1 protein.NLRP3 inflammasome is upregulated in neutrophilic asthma and may regulate the inflammation process observed in this asthma phenotype through production of IL-1β.

1 September 2007 in Blood
Verified
Journal Article
Closed access
PDF file
SPSimon Phipps
Simon Phipps
CLChuan En Lam
Chuan En Lam
SMSuresh Mahalingam
Suresh Mahalingam
MNMatthew Newhouse
Matthew Newhouse
RRRuben Ramirez
Ruben Ramirez
KMKlaus I. Matthaei
Klaus I. Matthaei
Eosinophils are recruited to the lungs in response to respiratory syncytial virus (RSV) infection; however, their role in promoting antiviral host defense remains unclear. Here, we demonstrate that eosinophils express TLRs that recognize viral nucleic acids, are activated and degranulate after single-stranded RNA (ssRNA) stimulation of the TLR-7–MyD88 pathway, and provide host defense against RSV that is MyD88 dependent. In contrast to wild-type mice, virus clearance from lung tissue was more rapid in hypereosinophilic (interleukin-5 transgenic) mice. Transfer of wild-type but not MyD88-deficient eosinophils to the lungs of RSV-infected wild-type mice accelerated virus clearance and inhibited the development of airways hyperreactivity. Similar responses were observed when infected recipient mice were MyD88 deficient. Eosinophils isolated from infected hypereosinophilic MyD88-sufficient but not MyD88-deficient mice expressed greater amounts of IFN regulatory factor (IRF)–7 and eosinophil-associated ribonucleases EAR-1 and EAR-2. Hypereosinophilia in the airways of infected mice also correlated with increased expression of IRF-7, IFN-β, and NOS-2, and inhibition of NO production with the NOS-2 inhibitor L-NMA partially reversed the accelerated virus clearance promoted by eosinophils. Collectively, our results demonstrate that eosinophils can protect against RSV in vivo, as they promote virus clearance and may thus limit virus-induced lung dysfunction.